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ABSTRACT: Needle crystals can cause filtering and handling problems
in industrial settings, and the factors leading to a needle crystal
morphology have been investigated. The crystal growth of the amide
and methyl, ethyl, isopropyl, and t-butyl esters of diflunisal have been
examined, and needle growth has been observed for all except the t-butyl
ester. Their crystal structures show that the t-butyl ester is the only
structure that does not contain molecular stacking. A second polymorph
of a persistent needle forming phenylsulfonamide with a block like habit
has been isolated. The structure analysis has been extended to known
needle forming systems from the literature. The intermolecular
interactions in needle forming structures have been analyzed using the
PIXEL program, and the properties driving needle crystal growth were
found to include a 1D motif with interaction energy greater than −30 kJ/
mol, at least 50% vdW contact between the motif neighbors, and a filled unit cell which is a monolayer. Crystal structures are
classified into persistent and controllable needle formers. Needle growth in the latter class can be controlled by choice of solvent.
The factors shown here to be drivers of needle growth will help in the design of processes for the production of less problematic
crystal products.
■ INTRODUCTION
Crystal morphology can have a major impact on the isolation
and downstream processing of active pharmaceutical ingredients
(APIs). Needle crystal morphology can be particularly problem-
atic in that needles are difficult to filter, tend to clog equipment,
and break easily creating unwanted fines.1−3 The factors
controlling crystal morphology, including needle crystal
morphology, have often been examined using the Bravais−
Friedel−Donnay−Harker method, BFDH,4 periodic bond
chain, PBC, analyses5,6 and slice attachment energies.7 There
have also been some theoretical simulations of crystal growth
mechanisms including Monte Carlo methods applied to
idealized growth units8 and molecular dynamics simulations
applied to both crystal growth and dissolution.9 The computa-
tionally demanding molecular dynamics simulations have thus
far only been applied to the simplest systems with few degrees of
freedom. A study of needle growth using PBC analysis combined
with crystal growth mechanisms has suggested that systems may
be divided into absolute and conditional needle formers.6,10 In
this paper we examine the structures of compounds from the
literature and new systems to determine the range of factors
which influence needle growth including the strength of the
intermolecular forces, molecular shape, and stacking motifs. We
will attempt to classify systems which can crystallize as needles
into persistent and controllable classes. The aim of the paper is
to provide criteria derived from crystal structures which will
indicate when it is worthwhile to try to control needle growth by
adjusting crystallization conditions. To this end we will first
briefly comment on needle growth and morphology prediction
and then discuss the crystal structures and the morphology of
diflunisal derivatives, of 2′-hydroxy[1,1′-bicyclohexyl]-1-car-
bonitrile and of a new polymorph and solvate of 4-hydroxy-N-
phenylbenzenesulfonamide, and finally analyze additional
examples of needle formers from the literature.
■ RESULTS AND DISCUSSION
Unique Properties of Needle Crystals. Needle crystals
are observed for crystal growth from the gas phase,11,12 from
solution,13 and from melts.14 Needle growth is also reversible
and needle crystals have been observed to get shorter faster than
they get thinner for both needle sublimation15 and needle
dissolution.16 During crystal growth needles have been observed
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to have smooth side faces and needle tips which have a rough or
rounded appearance.11,13,17,18 Since needle crystals with high
aspect ratios would be expected to have higher energies than
crystals with a more equant thermodynamically favored shape it
should be possible to observe a reduction of needle crystal aspect
ratios in solution under equilibrium conditions. This has in fact
been observed for isonicotinohydrazide and diflunisal needles in
ethanol at ambient temperature under high liquid shear low
mechanical attrition conditions.16
Crystal Growth Mechanisms. Just as crystal nucleation
requires the formation of a critical size cluster of molecules19 the
growth of a new layer on a smooth crystal face requires
nucleation. Calculations have shown that at low supersaturation
the rate of growth of a smooth crystal face should be close to
zero.20 However, if dislocations are present in the crystal
structure such as screw dislocations then smooth spiral growth at
low supersaturation becomes a favorable process.20 This Burton
Cabrera Frank, BCF, mechanism can lead to layer by layer
growth with the dislocation providing a constant source of
nucleation for new layers, Figure 1a. At higher supersaturation
levels it is believed that two-dimensional nucleation is possible
on a smooth crystal face and layer by layer growth is again
possible, Figure 1b.21 At even higher supersaturation a transition
to multimolecular layer or rough growth is possible, Figure 1c.22
For example, sucrose gives block like crystals with smooth
crystal faces when grown from aqueous solution with 2.2%
relative supersaturation, but at 5.1% supersaturation all faces
show rough growth without a change in crystal habit.23 In
contrast to what is observed for crystals with a block like habit,
the form I polymorph of p-aminobenzoic acid, PABA, grows as
needles from ethanol with a 2D birth and spread mechanism on
the needle side faces leading to smooth growth and a rough
growth mechanism, even at low supersaturations, on the needle
capping faces.24 Thus, needle growth differs from “normal”
crystal growth in that growth in the direction of the needle axis is
rough growth while the needle side faces always have smooth
growth. It has been estimated that the energy required for the
generation of a 2D nucleus on the needle tip faces of needle
forming β-triacylglycerol is close to zero and this is why its
needle tips always grow rough.25
It has also been shown that for needle crystal growth from the
gas phase the aspect ratio is inversely related to the
crystallization driving force for benzoic acid and 1,4-naphtho-
quinone12 and for β-phthalocyanine using two different
experimental setups.11,12 Any chemical process which shows
less discrimination at higher reaction rates is an example of the
reactivity selectivity principle, RSP, which was once believed to
have wide application in chemistry, but by the 1970s, it was
believed that there were many exceptions to RSP.26,27 More
recently and after much detailed examination it has been
suggested that as far as most chemical reactions are concerned
the idea is a myth.28 Nevertheless a significant number of
reactions still follow the principle, and a reduction in the
activation energy is related to a reduction in selectivity.29 Many
enantioselective catalysts show higher selectivity at lower
temperatures and lower reaction rates.30 The noncovalent
interactions which control the approach of substrates in chiral
catalysis31 are similar to the interactions involved in the addition
of a molecule in the correct orientation to a growing crystal and
lead to their adherence to RSP.
Crystal Morphology Predictions based on BFDH and
Slice Attachment Energy. Methods for the prediction of
crystal morphology have developed from the early work on the
BFDH method4 through the slice attachment energy model,
SAE,7,32,33 and modifications to attachment energy which try to
include the effect of solvent on solution grown crystals.34 These
methods are based on thermodynamic considerations alone in
that crystal growth is assumed to be driven by the energy
released when molecules are added to the growing crystal and
mechanistic factors are usually ignored. It is often stressed that
the BFDH method is based on the unit cell dimensions alone
and that it ignores the unit cell contents.35 Clearly the attempts
to improve BFDH morphology prediction using slice attach-
ment energies by calculation of intermolecular energies have a
sound logical basis; nevertheless, BFDH predictions of crystal
morphology are still widely used. A Google Scholar search using
the search term “BFDH” for the period 2000−2020 gave 1810
hits. It is important to understand why the BFDH method has
Figure 1. (a) Screw dislocation providing a constant nucleation source
for spiral growth at low supersaturation, (b) 2D nucleation at moderate
supersaturation, and (c) rough growth at high supersaturation.
Figure 2. Crystal morphology of PABA form I predicted by BFDH (a) simplified and ignoring space group extinctions, (b) including space group
extinctions, (c) SAE morphology calculated using the Habit program, and (d) PABA form I crystals grown by sublimation.
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such enduring appeal. The BFDH law states that the
morphological importance of a crystal face is directly propor-
tional to its d-spacing and extinctions due to translational
symmetry elements must be taken into account. A parallelepiped
shape is normally assumed.4 The morphologically important
faces are the slowest growing faces, and thus, the rate of growth
of a crystal face is inversely proportional to its d-spacing and
directly proportional to face area. This is illustrated using
calculated morphologies for PABA form I in Figure 2.
In Figure 2 the calculated morphologies all have lower aspect
ratios than the needle like crystals grown by sublimation. The b
unit cell face has the largest area, Figure 2c and Table 1, and the
(010) crystal face would be expected to have the fastest growth
rate. This is why it is invariably the case, as is discussed below,
that needle crystals grow in the direction of the shortest crystal
axis. The BFDH rule gives reasonable results in many cases
because in molecular crystals the larger the facial area the greater
the number of intermolecular interactions on that face and the
greater the energy released by growth in that direction. To a
considerable extent specific directional effects tend to average
out. Using the PABA form I structure it is possible to count the
number of accessible atoms in a unit cell face using a probe
moving on a 0.1 Å grid.36 The numbers of atoms encountered by
the probe, and the areas of the (100), (010), and (001) faces are
compared and scaled with errors in Table 1.
Despite the far from spherical shape of PABA form I the
numbers of H-bond donors and acceptors encountered on the
crystal faces are approximately in proportion to the face area.
Thus BFDH by a process of averaging gives a morphology
prediction that is based in a general way on the unit cell contents.
Periodic Bond Chains and Slice Attachment Energies.
The Hartman−Perdok theory is based on the concept of
periodic bond chains, PBCs.32 PBCs are secondary bonding
interactions between molecules in the lattice such as H-bonds,
dipole−dipole interactions, and vdW interactions which are all
termed bonds. Particular importance is attached to bond chains
which extend throughout the crystal structure. The usual
procedure is to first determine a set of strong bonds and then all
PBCs. Finally crystal faces are classified into F faces which have
slices containing two types of different PBCs, S type which have
one PBC, and K faces which contain none. Using estimated
energies for the bonds, the energy released by adding a crystal
slice to a particular face can be calculated; its slice attachment
energy, SAE, can be calculated, and the rate of growth of that
crystal face is then proportional to its SAE. However, if suitable
interatomic potential functions are used, SAEs can be calculated
without the need for the somewhat subjective PBC analysis,
Figure 1c.7,33
The observed morphology of PABA form I crystals grown
from a range of solvents is needle like with extended growth
along the b axis, and the needles are often hollow due to rapid
growth.37 PABA form I also grows as needles from the gas
phase38 where specific solvent effects are not involved, and as
pointed out above, the aspect ratio greatly exceeds the growth
rate that would be expected from BFDH, SAE, or indeed any
predictions based on thermodynamic considerations alone.
Substituent Effects on Needle Growth in Diflunisal
Derivatives. 5-(2,4-Difluorophenyl)-2-hydroxybenzoic acid or
diflunisal (DIF, Figure 3) has four known polymorphs all of
which crystallize as needles.39 The observation of needle growth
in DIF polymorphs and DIF cocrystals has been associated with
the presence of molecular stacking in their crystal structures.40
The methyl, ethyl, isopropyl, and tertiary butyl esters of DIF and
the acetonitrile solvate of diflunisal amide were crystallized, and
their crystal structures were determined to test the effect of these
substituents on needle growth. The crystal data for the diflunisal
esters are in Table S1, and more details of the structures are in
the Supporting Information, SI, including data for diflunisal
form III.
The extent to which molecular stacking influences needle
growth can be related to the intermolecular energy between
stack neighbors calculated by the PIXEL program41 and more
rapidly estimated by the percent of atoms in a molecule that are
in van der Waals (vdW) contact with their stack neighbors.40
These figures are given in Table 2 for DIF form III and the
diflunisal esters. While there is a small fall in the percent of atoms
in vdW contact from DIF form III to the isopropyl ester, the
values are all high (>70%) and there is a 50% increase in the
interaction energy. Packed unit cells of the ethyl and isopropyl
esters are shown in Figure 4.
In complete contrast to diflunisal and the other esters, the
tertiary butyl ester does not have a stacked structure and it
crystallizes as blocks. The asymmetric unit of the tertiary butyl
ester is shown in Figure 5a. The strongest intermolecular
interaction in the lattice at−47 kJ/mol is between the molecules
in the asymmetric unit and is more than twice that of the next
largest interaction. The tertiary butyl groups are too large to
allow efficient packing in a stacked structure. In the packing
Table 1. PABA Form I Face Areas and Numbers of Atoms on Faces Encountered by a Probe
face area/Å2 atoms atom number scaled to area HB donors HB donors scaled to area HB acceptors HB acceptors scaled to area
(100) 69.296 20 70.29 3 89.38 4 71.2
(010) 343.824 98 344.4 10 297.92 19 338.20
(001) 69.273 14 49.2 5 148.96 5 89.0
error 0.033 0.152 0.033
Figure 3. Structural formulas of the compounds used in this study.
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diagram in Figure 5b, a (020) slip plane is clearly present in the
structure.
Persistence of Needle Growth of DiflunisalMethyl and
Ethyl Ester. It has been reported that nitromethane has the
ability to block the growth of needle crystals in the cases of
PABA and lovastatin.42,43 It has been suggested that nitro-
methane has an ability to delaminate stacked structures.43 It was
found that when diflunisal and its methyl, ethyl, and isopropyl
esters were crystallized from nitromethane all grew as needles
except the isopropyl ester which grew as blocks. This is observed
despite the higher interaction energy within the stackingmotif of
the latter, Table 2. We attribute this lack of persistent needle
growth in the isopropyl case to increased opportunities for
solvent interactions provided by the structure with alternating
isopropyl groups, Figure 6.
The simple stacking in the case of the ethyl ester is due to the
presence of a monolayer in its crystal structure which is normal
to the 1D stacking motif, Figure 6a. In structures where the filled
unit cell is a monolayer the stacked molecules are symmetry
related by a unit translation in the stacking direction.
Diflunisal Amide Solvate. Diflunisal amide solvate
crystallizes as needles from acetonitrile. It has a stacked structure
with an intermolecular energy of −30.4 kJ/mol between stack
neighbors and more than 80% of the atoms are in vdW contact;
more details are in the SI.
Needle Growth of 4-Hydroxy-N-phenylbenzene-
sulfonamide. 4-Hydroxy-N-phenylbenzenesulfonamide
(HPS1) has been reported to crystallize as needles both from
solution and by sublimation.44 We now report that flash cooling
of dichloromethane solutions yields a second polymorph, HPS2,
which crystallizes as blocks, Figure 7c. Why is the strong
tendency toward needle growth observed for HPS1 absent in
HPS2? The crystal structure of HPS2 is compared with that of
HPS1 in Figure 7. In the HPS1 polymorph, each molecule is H-
bonded to two others and the H-bonded chains are stacked in
the direction of needle growth along the a axis with 52% vdW
Table 2. Properties and the Persistence of Needle Growtha
compound/polymorph
1D motifb, direction, and
energy/kJ/mol














stack c −30.6 87.5 0.22 yes 72.8 yes yes 48
diflunisal methyl ester stack a −33.6 82.76 0.41 yes 71.2 yes yes this
work
diflunisal ethyl ester stack a −40.7 82.81 0.40 yes 70.0 yes yes this
work
diflunisal i-propyl ester stack b −45.5 70.0 0.53 no 70.4 yes yes this
work
diflunisal t-butyl ester none 0.39 no this
work
diflunisal amide solvate stack b −30.4 83.3 0.48 yes 69.5 yes yes this
work
HPS1; VUKRAW stack a −35.1 51.79 0.75 yes 68.0 yes yes 44
HPS2 none 0.83 no 65.8 no no this
work
HPS aniline solvate stack a −48.9, −13.2 55.36, 46.43 0.53, 0.09 yes 70.7 yes yes this
work
HBCN s-HB c −32.1 3 0.66 no 66.5 yes no this
work
thymine; THYMIN03 d-HB b −74.8 20 0.29 yes 72.6 yes no 49
succinic acid; SUCACB18 d-HB along [101] −75.2 57, 54, 55 0.25 no 76.6 no no 50
D-mannitol; DMANTL01 t-HB c −99.9 56 0.42 yes 74.2 yes yes 51
aspartame hemihydrate;
DAWGOX
HB c −136.3, in stack disp
−60
57 0.40 yes 67.1 yes yes 52
aspartame; KETXIR HB b −98 −127 in stack
disp −60
52.55 0.69 yes 68.9 yes yes 53
3-isobutyl-1-methylxanthine;
CEWVIJ10
stack a −32.0 61.67 0.48 yes 70.9 yes yes 54
PABA form I; AMBNAC07 stack b −14.2 77.94 0.02 yes 73.5 yes no 37
PABA form V; AMBNAC09 stack b mean −14.3c 79.41 0.03 yes 74.0 yes no 55
MNA; MNIANL05 stack c −10.7 46.9 0.01 yes 72.6 yes no 56
NMBA; NMBYAN01 stack a −21.2 43.3 0.13 yes 75.9 yes no 57
β-phthalocyanine;
PHTHCY14
stack b −101.5 70.69 0.01 yes 72.7 yes yes 58
lovastatin; CEKBEZ01 stack a −54.8, s-HB b −31.6 42.31 0.72 yes 69.9 yes no 59
aCompounds indicated in the eighth column as persistent needle formers have a stacking interaction energy that is greater than −30 kJ/mol, >50%
of their atoms in vdW contact within the stack, and filled unit cells which are monolayers. bHB = hydrogen bond, s-HB = single hydrogen bond, d-
HB = double hydrogen bond, t-HB = triple hydrogen bond, in stack disp = dispersion energy. cThe asymmetric unit contains two molecules that
are both stacked.
Figure 4. Packed unit cells of (a) the ethyl ester and (b) the isopropyl
ester of diflunisal.
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contact between stacked neighbors.44 In the HPS2 structure,
each molecule is H-bonded to four others in a 3D arrangement
which maximizes H-bonding. An AM1 energy profile plot was
calculated for rotation about the H−N−S−O dihedral. The
HPS structure was first optimized and then the profile shown in
Figure 8 was calculated with all atoms in the structure being
optimized except the four atoms defining the dihedral. The angle
in the HPS2 structure obtained by flash cooling and that of
HPS1 are both close to the minimum energy. The relative
energy difference is small so that in this case the rotational angle
may not be decisive. On the basis of the density rule45 HPS2may
be the kinetic product, and HPS1, the more stable polymorph.
Their densities are 1.382 and 1.423 g/cm3, respectively.
However, it should be noted that a recent systematic analysis
suggested that 45% of a set of examples of monotropic phases
disobey the density rule.46
4-Hydroxy-N-phenylbenzenesulfonamide Aniline.
The crystal structure of the HPS aniline solvate is shown in
Figure 9. The molecules are stacked along the short a axis, and
the compound crystallized as needles. The mainly dispersive
interaction between the HPS molecules in the stacks is greater
Figure 5. (a) Asymmetric unit of diflunisal t-butyl ester and (b) packed units cell. One component of the ortho-F disorder is shown, andH atoms not in
H-bonds have been omitted for clarity.
Figure 6. Stacking in the structures of (a) the ethyl ester and (b) the
isopropyl ester of diflunisal.
Figure 7. H-bonding in the crystal structures of (a) HPS1, (b) HPS2, and (c) HPS2 crystal indexed on the diffractometer.
Figure 8. Energy profile plot for rotation about the H−N−S−O
dihedral of HPS.
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than in the HPS1 structure, and the HPS molecule adopts a
flatter geometry with a flatness index of 0.53 compared to 0.75
for HPS in the HPS1 structure (see the SI for the definition of
the flatness index). The H−N−S−O dihedral has a value of
−50.3°which takes themolecule close to the highest point of the
energy profile plot, Figure 8.
2′-Hydroxy[1,1′-bicyclohexyl]-1-carbonitrile. 2′-
Hydroxy[1,1′-bicyclohexyl]-1-carbonitrile, HBCN, was found
to crystallize as needles from nonhydroxylic solvents like
dichloromethane and as blocks from ethanol. Crystal data are
in Table S1, and more details are in the SI. The crystal structure
contains a 1D H-bond motif which is in the direction of needle
growth, Figure 10. The interaction energy between the
molecules in the H-bonded chain is −32.1 kJ/mol and just 3%
of the atoms are in vdW contact. Hydroxylic solvents are able to
suppress needle growth in this case. Hydroxylic solvents can
swamp the 1D directional H-bond and thus block the rapid
growth in the needle direction.
Can the Propensity to Yield Needle Crystals Be
Quantified? The crystal structures above which grow as
needles from the solvents examined all have stacked structures
with a stacking interaction that is greater than −30 kJ/mol, 50%
ormore of their atoms in vdW contact within the stack, and filled
unit cells which are monolayers. We classify these systems as
persistent needle formers. Both HBCN and the isopropyl ester
of diflunisal (with 3% vdW contact and a double layer unit cell
respectively) do not have all of these properties and are therefore
classified as controllable needle formers. To see if it is possible to
extend this classification of needle forming tendency to a wider
range of systems, we have examined literature examples of
compounds known to have polymorphs which exhibit needle
growth and combined them with the compounds described
above in Table 2. It was only possible to use examples from the
literature where the needle growth direction was clearly
established. This requirement greatly limited the number of
examples that could be included. The properties listed in Table 2
are
(i) the presence of a dominant 1D motif in the structure
which involves either stacking or H-bonding (or both),
and the interaction energy within the motif
(ii) in stacked structures the percent of the atoms in a
molecule that are in vdW contact with their stack
neighbors
(iii) molecular flatness defined as height/length; a flat
molecule has a flatness value close to zero and a spherical
molecule will have a value of 1; nonflat molecules which
have a high percent vdW contact in stacks are necessarily
well fitted into each other;47 more details are in the SI
(iv) a packed unit cell forms a monolayer normal to the
dominant 1D motif leading to simple stacking
(v) the packing index, an indication of a well packed structure
(vi) 1D motif aligned with the unit cell
Literature Examples of Compounds That Crystallize
As Needles. Thymine. Thymine (Figure 11) crystallizes from
90% H2O/ethanol as needles,
60 as prisms from ethanol, and as
plates by sublimation.61 The crystal structure contains a doubly
bondedH-bondmotif along the b axis with an interaction energy
of −74.8 kJ/mol between the molecules in the chains, Figure
12a. The fraction of atoms in vdW contact within the chains is
just 20% which is not sufficient to make needle growth
persistent, and crystal growth can be controlled by solvent
choice.
Succinic Acid. Succinic acid crystals grow by sublimation as
blocks, from H2O as plates, and as needles from isopropanol.
62
The H-bonded chains are parallel to the ac diagonal, Figure 12b.
Figure 9. HPS aniline solvate structure viewed down the a axis.
Figure 10. H-bonding in the crystal structure of HBCN.
Figure 11. Structural formulas of compounds that give needle crystals.
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The 1Dmotif is not aligned with the unit cell, and needle growth
can be controlled by solvent choice.
D-Mannitol. D-Mannitol grows from H2O as needles with
extended growth along c, Figure 13.63 Needle growth is also
observed from nitromethane. The triple H-bond with an
interaction energy between the molecules of −99.9 kJ/mol
combined with 56% vdW contact between the molecules in the
1D motif ensures that needle growth along c is persistent. It is
also important to note that D-mannitol is not flat. Its flatness
index is 0.42, and high vdW contact suggests that the molecules
are fitted into each other.
Aspartame. Aspartame hemihydrate has a very strong
tendency toward the growth of fine needles, and it was only
after considerable effort that needles of sufficient thickness could
be obtained for study by X-ray diffraction.52 The molecules
crystallize in the space group P41 with 0.5H2O. The zwitterionic
molecules are H-bonded in a spiral along the 41 screw axis at
each cell corner, Figure 14.
The water molecule is located in a channel down along c. It
makes a limited contribution to the overall charge assisted H-
bonding, and it does not play a crucial role in the structure. The
water molecule was therefore removed to make the PIXEL
calculations possible. The strong charge assisted H-bonding
with an interaction energy of −136.3 kJ/mol combined with
57% of the atoms in vdW contact in the 1Dmotif strongly favors
needle growth along the c axis. There are no H-bonds between
the stacks.
The crystal structure of the anhydrous form was determined
from powder data,13 and it is closely related to that of the
hemihydrate with similar charge assisted H-bonding supported
by vdW contact between the molecules in the 1D motif. Both of
these aspartame polymorphs are predicted to be persistent
needle formers, and so far, only needle morphology has been
reported in the literature.
3-Isobutyl-1-methylxanthine. 3-Isobutyl-1-methylxanthine
crystallizes from aqueous methanol as very fine needles.54 The
crystal structure contains H-bonded dimers which are stacked
along the short a axis, Figure 15. The interaction energy between
the molecules in the stacks is −32 kJ/mol and with a vdW
contact fraction of 62% needle growth is predicted to be
persistent.
p-Aminobenzoic Acid. PABA form I has been reported to
grow as needles from a range of solvents,10 and form V was
obtained as needles from an aqueous solution containing
Figure 12. H-bonding in (a) the crystal structure of thymine and (b) succinic acid (view down b).
Figure 13. Triple H-bond 1D motif of D-mannitol and crystal growth
along c.
Figure 14. (a) Aspartame hemihydrate, view down the c axis of one 41 screw axis, and (b) anhydrous aspartame, view down b of one 21 screw axis.
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selenous acid.55 Both of these forms have stacked structures
which are stacked in the direction of needle growth, Figure 16. In
both cases the fraction of atoms in vdW contact within the stacks
is close to 80%; however, the interaction energy between stack
neighbors is low at −14.2 and −14.3 kJ/mol, respectively, and
these values are just not high enough to ensure persistent needle
growth. It has recently been shown that block like crystals are
obtained from nitromethane.42
m-Nitroaniline and 4-Nitro-4′-methyl Benzylidene Aniline.
m-Nitroaniline, MNA, and 4-nitro-4′-methyl benzylidene ani-
line, NMBA, are nonlinear optical materials which have similar
crystal growth patterns. Both show low solubility in n-hexane
from which they crystallize as needles.64,65 The strongest
interaction in them-nitroaniline structure,−25.2 kJ/mol, is a 1D
H-bond parallel to the bc diagonal, Figure 17a, which does not
influence crystal growth. It is the weaker stacking interaction
along c which drives needle growth. From other solvents in
which they are more soluble including CCl4, methanol, and
toluene, the crystals have a more equant shape. The stacking
interaction along a in NMBA (Figure 17b) has an energy of
−21.2 kJ/mol. MNA and NMBA are controllable needle
formers.
β-Phthalocyanine. β-Phthalocyanine crystallizes in space
group P21/n with a half molecule in the asymmetric unit. The
molecule was completed and the space group was reduced to P21
to make PIXEL calculations possible. In the crystal structure the
molecules are in slipped stacks. In Figure 18, molecules 1 and 2
are in a stack and molecules 3−6 are the closest contacts to
molecule 1 in neighboring stacks. The interaction energies
between molecule 1 and molecules 2−6 are −101.5, −29.4,
−29.4, −27.6, and −27.6 kJ mol−1, respectively. It is the strong
dispersion dominated 1D interaction within the stacks with 71%
vdW contact between the molecules which drives the persistent
needle growth along the short b axis; more details are in the SI.
Lovastatin. Lovastatin has been reported to crystallize as
needles from alcohols and as rods from ethyl acetate. The crystal
structure viewed down the a axis shows that there is a 1D
stacking motif present, Figure 19. The strongest interaction in
the lattice is between the molecules within the stacks. However,
the fraction of atoms in vdW contact at 42% is low enough to
allow nonhydroxylic solvents especially nitromethane43 to
delaminate the stacks, control needle formation, and yield a
more equant crystal shape.
Simulation of Crystal Dissolution. Molecular dynamics
simulation of pharmaceutical type crystal dissolution has been
used to compare different force fields and to estimate heats of
solution for aspirin, ibuprofen, and paracetamol.66 Amber and
Charmm force fields were found to give reasonable results. The
mechanism of the dissolution of aspirin crystals has been
compared to experimental observations using 4079 molecule
clusters.67 A molecular dynamics study of the dissolution of p-
aminobenzoic acid found that clusters of less than 300molecules
were not stable in aqueous solution.68 Larger clusters of up to
504 molecules were stable at 0 °C but less stable at 50 and 100
°C.
We were interested to see if simulation of crystal dissolution
could reproduce the observation that needle crystals get shorter
faster than they get thinner as they dissolve. This should be seen
as a faster rate of dissolution of the tops of the molecular stacks
in stacked structures than at the stack sides.
Simulations were carried out using Yasara with the Amber14
force field.69,70
Diflunisal Ethyl Ester. A 240 molecule cluster in a
simulation box with 4675 molecules of ethanol was used. After
800 ps, molecules leave the both ends of the stacks. After 3000 ps
there is considerable disruption of the ends of the stacks. Using
the same 240 molecule cluster in a simulation box with 4686
molecules of nitromethane after 300 ps, molecules begin to leave
from the ends of the stacks and at 3000 ps a much larger number
of molecules have left the cluster than in the ethanol run, Figure
20. There are dissolution movies in the SI. This simulation
reproduces the observation that dissolving needles get shorter
before they get thinner and the delaminating effect of
nitromethane.
PABA Form I. A 576 molecule supercell of PABA form I in a
simulation box with 4288 molecules of ethanol was compared to
the same super cell with 4480 molecules of nitromethane. In
both cases rapid dissolution took place and after 3000 ps the
stacks are more disrupted in nitromethane than in ethanol,
Figure 15. Crystal structure of 3-isobutyl-1-methylxanthine.
Figure 16. Structure of PABA viewed down b (a) form I and (b) form V.
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Figure 21. This would seem to support the suggestion that
nitromethane delaminates π-stacked PABA form I.42
Needle Growth and Needle Dissolution. It has been
stressed above that the strength of the bonding within the 1D
motif is an important factor driving needle growth. It thus might
appear reasonable to argue that these strong intermolecular
interactions within the 1D motif would slow dissolution at the
top and bottom of the stacks. However, due to the high fraction
of atoms in the molecules that are in vdW contact within the
stacks the same fraction will be exposed to solvent interactions at
the end of the stacks. It is this labilization of the exposed
molecules at the stack ends that contributes to making the
processes of needle growth and dissolution reversible.
Classification of Needle Crystals. Needle crystals have
been classified as being either absolute or conditional needles.
Absolute needles being those that will grow as needles from all
solvents tested and conditional needles have aspect ratios which
depend on solvent.6 It was originally suggested that PABA form I
was an example of an absolute needle;10 however, subsequent
work based on morphology predicted using periodic bond chain
analysis combined with smooth growth mechanisms suggested
that it was a conditional needle.6
We propose the use of the terms persistent and controllable
for systems which crystallize with a needle morphology.We have
shown that systems classified as persistent needle formers have a
consistent set of properties and that systems which do not have
these properties have morphologies which can be controlled by
solvent choice. The most important properties which drive
needle growth are stacking within a 1D motif with more than
−30 kJ/mol interaction energy and at least 50% vdW contact
and a monolayer filled unit cell. The only effective way to
eliminate persistent needle growth is to find another nonstacked
Figure 17. (a) MNA H-bond between molecules 3, 1, and 2 and molecules 5, 1, and 4 are stacked and (b) stacking in NMBA.
Figure 18. Crystal structure of β-phthalocyanine.
Figure 19. Crystal structure of lovastatin viewed down the stacks.
Figure 20. (a) Diflunisal ethyl ester supercell 0 ps, (b) simulation in EtOH after 3000 ps, and (c) simulation in MeNO2 after 3000 ps.
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polymorph or to introduce a substituent into the structure which
hinders molecular stacking.
■ CONCLUSIONS
The amide and methyl, ethyl, and isopropyl esters of diflunisal
crystallize as needles from ethanol. The t-butyl ester crystallizes
as blocks from all solvents examined. Of these compounds the t-
butyl ester is the only one that does not have a 1D stacking motif
in its structure.
Needle growth is reversible in that on dissolution or
sublimation needle crystals get shorter faster than they get
thinner. This observation has been reproduced by molecular
dynamics simulation of dissolution.
An analysis of intermolecular energies calculated using the
PIXEL program suggests that the interaction energy within the
1Dmotif has an important influence on the persistence of needle
growth from a range of solvents.
The structures of known needle forming systems from the
literature were added to the structures reported here, and the
crystal structural features required to drive persistent needle
formation were found to be a stacked structure with a stacking
interaction that is greater than−30 kJ/mol, 50% ormore of their
atoms in vdW contact within the stack, and filled unit cells which
were monolayers.
Compounds whose structures have some but not all of these
properties can crystallize as needles from some solvents and as
blocks from others.
This permits the classification of crystal structures into
persistent and controllable needle formers. To stop needle
growth by persistent needle formers it is necessary to find a
nonstacked polymorph or to synthesize a derivative with a
substituent which blocks stacking in the crystal structure.
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